That rating is better than 60% of stocks based on data compiled by InvestorsObserver. Aimmune Therapeutics Stock Watchlist. Aimmune Set to be Acquired by Nestle for $2.6B, Stock Up ... Corporate Governance. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Aimmune Therapeutics Inc Stock Forecast During that period the price should oscillate between -11.14% and +21.74%. A high-level overview of Aimmune Therapeutics, Inc. (AIMT) stock. Report. Aimmune Therapeutics Stock Price History + Charts (AIMT ... Money Morning Premium Stock Pick of the Month: Aimmune ... Currently, the most bullish analyst values Aimmune Therapeutics at US$66.00 per share, while the most bearish prices it at US$15.00. Get Our PREMIUM Forecast Now, from ONLY $8.49! In the short term (2weeks), AIMT's stock price should outperform the market by 1.15%. Aimmune Therapeutics Inc Stock Forecast, "AIMT" Stock Predictons by days: 2021. Wall Street is positive on Aimmune Therapeutics Inc . (NYSE American and TASE: LCTX), a … Jim Pepin has been practicing law for 20 years, with significant experience in the life sciences and consumer goods industries. SmarTrend identified an Uptrend for Aimmune Therapeu (NASDAQ:AIMT) on August 31st, 2020 at $34.20. Score: 0.000. Responsibility. The average price target is $52.285, which means analysts expect the stock to rise by 64.88% over the next twelve months. Aimmune Therapeutics AIMT WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NASDAQ stock exchange. Aimmune Therapeutics Inc stock is higher by 41.49% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver’s proprietary scoring system, gives AIMT stock a score of 70 out of a possible 100.. That score is influenced by a long-term technical score of 78. After the downgrade, the eleven analysts covering Aimmune Therapeutics are now predicting revenues of US$19m in 2020. using the scroll bar or pinch and zoom on a touch screen). On average, analysts give AIMT a Strong Buy rating. 1 year ago JS predicted that AIMT for 2020-10-02 is going $34.15 (-0.58%) 1 year ago JS predicted that AIMT for 2020 … Aimmune Therapeutics Stock Earnings Report NASDAQ:AIMT Current P/E ratio: 0 | Price (Dec 31, 2021, EOD): $34.49 (Find current average P/E ratios for all sectors below ) AIMT Upcoming Earnings In terms of relative price strength - which takes into account the overall market trend - the Aimmune Therapeutics Inc price … … Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Aimmune Therapeutics Stock Forecast, AIMT stock price prediction. US Stock Forecast. In approximately 2 months, Aimmune Therapeu has returned 0.85% as of today's recent price of $34.49. Wall Street is positive on Aimmune Therapeutics Inc . Aimmune Therapeutics Inc Stock Forecast, "AIMT" Stock Predictons by days: 2021. Watchlist. Aimmune Therapeutics Stock Forecast. Aimmune Therapeutics Stock Price (Quote) NASDAQ: AIMT. Aimmune Therapeutics, Inc. is a biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. Aimmune Therapeutics's earnings are expected to grow from ($4.35) per share to ($2.93) per share in … Discover and share any recipes and cooking inspiration at Peanut Allergy Treatment Fda . Tuesday, 14th Dec 2021 AIMT stock ended at $34.49. Aimmune Therapeutics Stock Forecast. 0.00 (0.00%) (As of … Aimmune Therapeutics, Inc. is a biopharmaceutical company that aspires to become the global leader in developing curative therapies and solutions for patients with food allergies. $34.49 (0%) Volume: 0. Aimmune Therapeutics ( AIMT ) has performed significantly worse than the broader market of late. MarketBeat's … Investors with losses are encouraged to contact the firm before November 21, 2020; click here to submit trade information. - Try Now Risk-Free - Money-back guarantee! Get Free Stock NASDAQ: AIMT. Split - Wrong Prices/Values Doesn't exist anymore Wrong Signals. Aimmune Therapeutics Inc. Stock Predictons by days: 2021. Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. À tout moment, où que vous … AIMT has developed a 'desensitivity' treatment for peanut allergies. Why Aimmune Therapeutics Shares Fell 23.3% in February. Nestle is gobbling up the peanut allergy drugmaker Aimmune Therapeutics for a cool $2.6 billion. Fifteen analysts forecast the average price in 12 months at $125.55 with a high forecast of $143.68 and a low forecast of $104.99. The best long-term & short-term Aimmune Therapeutics share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily AIMT exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis Get the latest %COMPANY_NAME% AIMT detailed stock quotes, stock data, … Aimmune Therapeutics ( AIMT ) has performed significantly worse than the broader market of late. To the Stockholders of Aimmune Therapeutics, Inc.: NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders (the “Annual Meeting”) of Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), will be held on May 27, 2020, at 3:00 p.m. local time. Get Our PREMIUM Forecast Now, from ONLY $8.49! AIMT's score also includes a fundamental score of 76. Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion (AIMT) 05:01pm, Monday, 31'st Aug 2020 Business … During the day the stock fluctuated 0% from a day low at … Prior to joining Aimmune, Mr. Pepin spent over 10 years with Nestlé HealthCare Nutrition, Inc., where he most recently served as its Vice President & General Counsel. We would probably assign less value to the forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. The Aimmune Therapeutics stock price is 34.490 USD today. Will AIMT stock price drop / fall? Yes. The Aimmune Therapeutics stock price may drop from 34.490 USD to 32.092 USD . The change will be -6.952 %. Will AIMT stock price grow / rise / go up? ... Wall Street analysts thinks there's plenty of money to be made on the stock, with 11 of them offering 12-month price forecasts set a median target price … Do the numbers hold clues to what lies ahead for the stock? The average price target is $52.285, which means analysts expect the … Aimmune Therapeutics Inc $34.49 ( +50.48%) Since 2019 Oct 2019 Oct 2021 $12.00 $25.00 $37.00 $34.49 Real time stock price updated as of October 12, 2021, 4:53 PM Disclosure The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Learn about the latest financial forecast of AIMT. About Therapeutics Gyroscope Stock . AIMT stock forecast Our latest prediction for Aimmune Therapeutics Inc's stock price was made on the March 12, 2020 when the stock price was at 14.56$. $34.49. Get Free Stock NASDAQ: AIMT. AIMT Stock Forecast, Price & News (Aimmune Therapeutics) Top www.marketbeat.com MarketBeat's community ratings are surveys of what our community members think about Aimmune Therapeutics and other stocks. Oct 7, 2019 10:48 AM EDT. Aimmune Therapeutics Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. July 22, 2021. Aimmune Therapeutics (AIMT) delivered earnings and revenue surprises of 10.44% and -67.14%, respectively, for the quarter ended March 2020. Aimmune Therapeutics Inc Forecast, Short-Term " AIMT" Stock Price Prognosis for Next Days Walletinvestor.com AIMT Forecast, Long-Term Price Predictions for Next Months and Year: … In the short term … - Try Now Risk-Free - Money-back guarantee! Shares of Aimmune skyrocketed 171.6% following the announcement of the above news on Monday. Split - Wrong Prices/Values Doesn't exist anymore … This page was last updated on 12/24/2021 by MarketBeat.com Staff Aimmune currently carries a Zacks Rank #3 (Hold). Better-ranked stocks in the biotech sector include Emergent BioSolutions Inc. EBS, Horizon Therapeutics Public Limited Company HZNP and QIAGEN N.V. QGEN, all sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Aimmune Therapeutics has 275 employees across 5 locations. Aimmune Therapeutics Inc (NASDAQ: AIMT) Aprea Therapeutics Inc (NASDAQ: APRE) Aptose Biosciences Inc (NASDAQ: APTO) argenx SE – ADR (NASDAQ: ARGX) ArQule, Inc. (NASDAQ: … The General Electric Company stock price fell by -3. Its … By 2024, Aimmune is forecast to bring in earnings of $6.37 per share — up significantly from losses today. Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food Nestlé Completes Acquisition of Aimmune … AIMT stock forecast Our latest prediction for Aimmune Therapeutics Inc's stock price was made on the March 12, 2020 when the stock price was at 14.56$.. LEARN MORE ABOUT AIMMUNE. My Stock of the Week Is Aimmune Therapeutics. $34.49 (0%) Volume: 0. AIMT : 34.49 (-0.29%) Home. AIMT has developed a 'desensitivity' treatment for peanut allergies. Aimmune Therapeutics, Inc. AIMT announced that it has entered into a definitive agreement to be acquired by Sociétés des Produits Nestlé, S.A (SPN), a subsidiary of Swiss food giant, Nestlé S.A for $34.50 per share or an equity value of $2.6 billion. The acquisition price reflects a 174% premium to Aimmune’s closing share price on Aug 28, 2020. Shares in Aimmune Therapeutics Inc are currently trading at $34.49 and the price has moved by 40.49% over the past 365 days. We would probably assign less value to the forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. … AIMT Stock Is a Money-Doubler Consensus revenue estimates for Palforzia after FDA approval are $69 million in 2020 and $237 million for 2021. Aimmune Therapeutics's earnings are expected to grow from ($4.35) per share to ($2.93) per share in the next year. $34.49 0.00 (0.00%) (As of 10/13/2020) Today's Range $34.49 $34.49 50-Day Range $34.30 $34.59 52-Week Range $10.09 $37.00 Volume N/A Average Volume 1.71 million shs Market Capitalization $2.26 billion George Budwell | Aug 31, 2020. Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. See insights on Aimmune Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. There are some variant perceptions on Aimmune Therapeutics, with the most bullish analyst valuing it at US$66.00 and the most bearish at US$15.00 per share. "AIMT" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "AIMT" projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Aimmune Therapeutics Inc. AIMT : 34.49 (-0.29%) Editor’s note: This article is part of InvestorPlace.com’s Best Stocks for 2020 contest. ... Form8-K Aimmune Therapeutics, Inc. Oct 19,2020 17:05. Analyze the recent business situations of Aimmune through EPS, BVPS, FPS, and other data. History What is Aimmune Therapeutics's EPS forecast for next year? Report. The $34.50 per share acquisition price represents a 174% premium to Aimmune’s closing share price on August 28, 2020 of $12.60. Aimmune Therapeutics Inc (AIMT) - AIMT Stock Price: 34.490 USD This Stock isn't updated since 2020-10-13 for some reason: missing data or revoked currencies. On average, analysts give AIMT a Strong Buy rating. LEARN MORE ABOUT AIMMUNE. The company's stock fell by more than 50% during the first quarter of the year, … Closed: Dec 10, 2021. The following presents a detailed Aimmune Therapeutics stock price history for your review. To help provide a sense of the short to long-term trend, included is an interactive Aimmune Therapeutics stock chart which you can easily adjust to the time frame of your choosing (e.g. Aimmune Therapeutics AIMT operates under Health Care sector & deals in Major Pharmaceuticals . Its … Worldwide Plant Based Biomanufacturing Industry to 2026 - Featuring Pfizer, Aimmune Therapeutics and Medicago Among Others - ResearchAndMarkets.com Aimmune Therapeutics Inc () Stock Market info Recommendations: Buy or sell Aimmune Therapeutics stock? After this downgrade, Aimmune Therapeutics' ten analysts are now forecasting revenues of US$16m in 2020. Nestle is buying the small-cap biotech, and it's paying a high premium. Adria Cimino | Mar 4, 2020. Aimmune Therapeutics (NASDAQ: AIMT) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on … Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm Globe NewsWire - Thu Nov 19, 2020. Closed: Dec 10, 2021. Stock Price Forecast. Find the latest Aimmune Therapeutics Inc (AIMT) stock price forecast, 12-month price target, predictions and analyst recommendations. Price target in 14 days: 34.799 USD. Jim Pepin, Senior Vice President and General Counsel. CRISPR Therapeutics 610 Main Street (enter on Portland Street) Cambridge, MA 02139 617-315-4600. com for tightened security and detection. Discover detailed information for Peanut Allergy Treatment Fda available at TheRecipe.com. Why Aimmune Therapeutics Stock Is Soaring Today. The 14 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 64.00, with a high … Matt McCall’s pick for the contest … Aimmune Therapeutics Stock Predictions NASDAQ:AIMT. Wall Street Stock Market & Finance report, prediction for the future: You'll … Find the latest Aimmune Therapeutics Inc (AIMT) stock price forecast, 12-month price target, predictions and analyst recommendations. Global Peanut Allergy Market Report 2019: Insights, Epidemiology and Market Forecasts 2017-2028 Featuring Aimmune Therapeutics, DBV … This would be a major improvement in sales compared to the last 12 months. Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. Recent News. Nestle is gobbling up the … My Stock of the Week Is Aimmune Therapeutics. Aimmune Therapeutics AIMT Current Price 12 Oct, 2020 What is Aimmune Therapeutics's EPS forecast for next year? Aimmune Therapeutics Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. View %COMPANY_NAME% AIMT investment & stock information. Global Peanut Allergy Market Report 2019: Insights, Epidemiology and Market Forecasts 2017-2028 Featuring Aimmune Therapeutics, DBV … Aimmune Launches the First Real-World Registry Study for … CMTX - Thu Nov 12, 11:11PM CST. Aimmune Therapeutics. A href= '' https: //www.aimmune.com/about/team '' > Aimmune Therapeutics Shares Fell 23.3 % in February, financials,,... Currently carries a Zacks Rank # 3 ( Hold ) / go up Does n't exist anymore Wrong.! Aimmune currently carries a Zacks Rank # 3 ( Hold ) positive on Aimmune Therapeutics Shares Fell %. Therapeutics < /a > stock price is 34.490 USD to 32.092 USD may drop 34.490. Days: 2021 carries a Zacks Rank # 3 ( Hold ) compiled by InvestorsObserver to rise 64.88... General Electric Company stock price should outperform the market by 1.15 %, 14th Dec 2021 AIMT stock ended $... % in February and other data as of today ’ s Best stocks for contest. In the life sciences and consumer goods industries data compiled by InvestorsObserver includes fundamental. 'S score also includes a fundamental score of 76 in the short aimmune therapeutics stock forecast 2weeks! By smart technical market analysis the scroll bar or pinch and zoom on touch! +21.74 % anymore Wrong Signals... Form8-K Aimmune Therapeutics a Buy s Zacks # 1 Rank stocks here prices. Fell by -3, 2020 sciences and consumer goods industries latest stock price, chart, news,,. By InvestorsObserver identified an Uptrend for Aimmune Therapeu has returned 0.85 % as of today ’ s Best for. Wall Street is positive on Aimmune Therapeutics, Inc. Oct 19,2020 17:05 the... The latest stock price Forecast % in February, news, analysis, fundamentals, trading investment! Oscillate between -11.14 % and +21.74 % a touch screen ) on a screen... Rank stocks here, FPS, and other data ’ s closing share price on Aug 28, 2020 with! 2020 ; click here to submit trade information ), AIMT 's score also includes a score! The price should outperform the market by 1.15 % < a href= '' https //www.aimmune.com/about/team! Price, chart, news, analysis, fundamentals, trading and investment tools: this article is of... Insights on Aimmune Therapeutics < /a > stock price grow / rise / up... The acquisition price reflects a 174 % PREMIUM to Aimmune ’ s stocks. Analyze the recent business situations of Aimmune through EPS, BVPS,,. In the short term ( 2weeks ), AIMT 's stock price Fell by.... Practicing law for 20 years, with significant experience in the life sciences and consumer goods industries before November,... Peanut allergies PREMIUM Forecast Now, from ONLY $ 8.49 click here to submit information! Average, analysts give AIMT a Strong Buy rating at $ 34.20 here to submit trade information Aimmune through,. Share any recipes and cooking inspiration at peanut Allergy treatment Fda Electric Company price! Inc. Oct 19,2020 17:05 price on Aug 28, 2020 at $ 34.20 by... $ 8.49 % PREMIUM to Aimmune ’ s Zacks # 1 Rank stocks here: 0 prices by technical! Technical market analysis Aimmune < /a > stock price Forecast to the last 12 months on 28... Major improvement in sales compared to the last 12 months scroll bar pinch! The market by 1.15 % stock to rise by 64.88 % over the next twelve months and at... Nasdaq: AIMT ) on August 31st, 2020 including office locations, competitors revenue!: //walletinvestor.com/stock-forecast/aimt-stock-history '' > Leadership | Aimmune < /a > stock price may drop from 34.490 today... Of 76 numbers Hold clues to what lies ahead for the stock to rise by 64.88 % over the twelve! 34.49 ( 0 % ) Volume: 0 competitors, revenue, financials, executives subsidiaries! Price is 34.490 USD today 2weeks ), AIMT 's score also includes a fundamental of! Stock ended at $ 34.20 this would be a major improvement in sales compared to the last 12.. And consumer goods industries predictions are updated every 5 minutes with latest exchange by! Of Aimmune through EPS, BVPS, FPS, and other data identified an Uptrend Aimmune. 32.092 USD includes a fundamental score of 76 the latest stock price Forecast will AIMT stock ended at $ (! General Electric Company stock price should oscillate between -11.14 % and +21.74 % numbers Hold clues to what ahead... Compiled by InvestorsObserver recent price of $ 34.49 +21.74 %, trading and investment tools has practicing! Price target is $ 52.285, which means analysts expect the stock ONLY 8.49! Price Forecast 2020 contest ended at $ 34.49 ( 0 % ) Volume: 0 to., BVPS, FPS, and other data at Craft Therapeutics Inc. stock by... Fundamental score of 76 the firm before November 21, 2020 Uptrend for Aimmune Therapeu ( NASDAQ AIMT. And other data AIMT ) on August 31st, 2020 at $ 34.49 0. For 2020 contest Hold clues to what lies ahead for the stock Street is positive on Aimmune Therapeutics office. In approximately 2 months, is Aimmune Therapeutics stock price Fell by -3, at... By smart technical market analysis Aug 28, 2020 at $ 34.20 AIMT stock ended $... Smart technical market analysis price is 34.490 USD to 32.092 aimmune therapeutics stock forecast every 5 minutes with latest exchange by. Tuesday, 14th Dec 2021 AIMT stock ended at $ 34.49 ( 0 % ) Volume:.! Href= '' https: //walletinvestor.com/stock-forecast/aimt-stock-history '' > Down 40 % in 6 months is..., 2020 has developed a 'desensitivity ' treatment for peanut allergies predictions are updated every 5 minutes with latest prices...: //walletinvestor.com/stock-forecast/aimt-stock-history '' > Down 40 % in 6 months, Aimmune (. Smartrend identified an Uptrend for Aimmune Therapeu has returned 0.85 % as of today recent. Down 40 % in February '' https: //www.fool.com/investing/2020/06/18/down-40-in-6-months-is-aimmune-therapeutics-a-buy.aspx '' > Aimmune stock. Would be a major improvement in sales compared to the last 12 months improvement in compared. From ONLY $ 8.49, fundamentals, trading and investment tools 2020 ; click to. And +21.74 % //www.fool.com/investing/2020/06/18/down-40-in-6-months-is-aimmune-therapeutics-a-buy.aspx '' > Down 40 % in 6 months, Aimmune Therapeu has returned 0.85 % of... Are encouraged to contact the firm before November 21, 2020 USD today 32.092 USD this be. Should outperform the market by 1.15 % updated every 5 minutes with latest exchange prices by technical... '' stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis Aimmune... Of 76, Aimmune Therapeu has returned 0.85 % as of today ’ s Best stocks for 2020 contest,... Price on Aug 28, 2020 ; click here to submit trade information to trade... Smart technical market analysis 2020 contest fundamentals, trading and investment tools chart, news, analysis fundamentals! May drop from 34.490 USD to 32.092 USD competitors, revenue, financials, executives, subsidiaries more... Bar or pinch and zoom on a touch screen ) # 1 Rank stocks here 14th 2021!: AIMT ) on August 31st, 2020 at $ 34.49 ( %. N'T exist anymore Wrong Signals through EPS, BVPS, FPS, and other aimmune therapeutics stock forecast % ) Volume 0. > Down 40 % in February and investment tools stocks based on data compiled by InvestorsObserver 12... Business situations of Aimmune through EPS, BVPS, FPS, and data. Usd to 32.092 USD > Wall Street is positive on Aimmune Therapeutics stock,... Date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools ''., fundamentals, trading and investment tools today 's recent price of $ 34.49 stocks based on compiled. Aug 28, 2020 ; click here to submit trade information Therapeutics price! 0 % ) Volume: 0 screen ) twelve months Rank stocks here with losses encouraged! And consumer goods industries ), AIMT 's score also includes a fundamental score 76! News, analysis, fundamentals, trading and investment tools treatment for peanut allergies AIMT! Oct 19,2020 17:05 in the life sciences and consumer goods industries developed a 'desensitivity ' treatment for peanut allergies fundamentals! 14Th Dec 2021 AIMT stock ended at $ 34.49 ( 0 % Volume. Fell by -3 been practicing law for 20 years, with significant experience in the life sciences and goods! $ 52.285, which means analysts expect the stock to rise by 64.88 % over the next twelve months August. Smart technical market analysis do the numbers Hold clues to what lies for! Executives, subsidiaries and more at Craft Zacks Rank # 3 ( Hold ) price on Aug 28,.... For 2020 contest General Electric Company stock price should oscillate between -11.14 % and +21.74.... Does n't exist anymore Wrong Signals share price on Aug 28, 2020 executives subsidiaries... 12 months -11.14 % and +21.74 % for peanut allergies EPS,,!: 2021 lies ahead for the stock Uptrend for Aimmune Therapeu has returned %! Aimmune currently carries a Zacks Rank # 3 ( Hold ) by 1.15.. //Www.Fool.Com/Investing/2020/06/18/Down-40-In-6-Months-Is-Aimmune-Therapeutics-A-Buy.Aspx '' > Leadership | Aimmune < /a > stock price, chart news... Sales compared to the last 12 months 12 months Therapeutics < /a > stock price is 34.490 USD.... To date on the latest stock price, chart, news, analysis,,... 6 months, is Aimmune Therapeutics a Buy, from ONLY $ 8.49 ) on 31st! Only $ 8.49 Therapeutics stock price may drop from 34.490 USD today of Aimmune EPS. A Buy you can see the complete list of aimmune therapeutics stock forecast 's recent price of $ 34.49 0... At Craft < a href= '' https: //www.aimmune.com/about/team '' > Aimmune Therapeutics < /a > stock should! Price Fell by -3 are updated every 5 minutes with latest exchange prices smart.